Description
Safety data including adverse events (erythema, pain, scaling) recorded across treatment groups in the microneedling hair loss trial.
Fig. 6
ChartSource Paper
Evaluating the efficacy and safety of combined microneedling therapy versus topical Minoxidil in androgenetic alopecia: a systematic review and meta-analysis.Cite This Figure
 > Source: Khalid M A Ahmed et al. "Evaluating the efficacy and safety of combined microneedling therapy versus topi." *Archives of dermatological research*, 2025. PMID: [40056230](https://pubmed.ncbi.nlm.nih.gov/40056230/)
<figure> <img src="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11890238/bin/403_2025_4032_Fig6_HTML.jpg" alt="Safety data including adverse events (erythema, pain, scaling) recorded across treatment groups in the microneedling hair loss trial." /> <figcaption>Fig. 6. Safety data including adverse events (erythema, pain, scaling) recorded across treatment groups in the microneedling hair loss trial.<br> Source: Khalid M A Ahmed et al. "Evaluating the efficacy and safety of combined microneedling therapy versus topi." <em>Archives of dermatological research</em>, 2025. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40056230/">40056230</a></figcaption> </figure>